Part II: Datasets

AD Dataset Catalogue

A comprehensive, community-maintained catalogue of datasets available for Alzheimer's disease research. Covers neuroimaging, genetics, proteomics, exposomics and beyond. Contributions welcome via GitHub Pull Request.

Historical Chronology of AD Datasets

1958 – 2021

Click any entry to expand. The timeline reflects the first publication / establishment date of each dataset.

North America
Europe
Asia-Pacific / Latin America
LMIC
Multi-national
1958
BLSA
▼
1979
Knight ADRC
▼
1992
WHICAP
▼
1994
ROSMAP
▼
1999
NACC
▼
2001
WRAP
▼
2004
ADNI
▼
2005
AddNeuroMed
▼
2006
AIBL
▼
2006
UK Biobank
▼
2011
PREVENT-AD
▼
2014
A4 Study
▼
2015
EPAD
▼
2015
DELCODE
▼
2016
EMIF-AD
▼
2017
LASI-DAD
▼
2019
OASIS-3
▼
2019
ReDLat
▼
2021
ANMerge
▼

Click any entry to expand. Colour indicates geographic origin.

Neuroimaging, Genetics & Multi-modal Datasets

Filter, sort, and search across all documented datasets. Click a row to expand details and notes.

Contribute
Loading dataset catalogue…

Proteomics, Exposomics & Emerging Modalities

Beyond neuroimaging and genetics, a new wave of datasets now incorporates proteomics (CSF and plasma, e.g. ROSMAP, Knight ADRC), transcriptomics (brain tissue RNA-seq via AMP-AD), epigenomics (DNA methylation), and exposomics (environmental exposure indices, notably UK Biobank). The integration of these modalities into a single analytical framework is increasingly necessary to capture the full biological complexity of AD and to identify population-specific mechanisms that single-modality studies miss.

🧪
Proteomics
ROSMAP, Knight ADRC, EMIF-AD
🌿
Exposomics
UK Biobank
🧬
Transcriptomics
ROSMAP, AMP-AD
🔬
Epigenomics
ROSMAP, ADNI